en
/
sv
About Elicera
Elicera in brief
Board
Management
Elicera's history
Immuno-oncology
What is immuno-oncology?
Oncolytic virus
CAR T-cell therapy
Technology
Strengths
ELC-001
ELC-100
ELC-201
ELC-301
ELC-401
Patents
Pipeline
Pipeline
Clinical trials
Investors
Press Releases
Corporate Governance
the Share
Financial Reports
Financial Calendar
Events
Planned IPO
News
News
Press Releases
Events
Contact
en
/
sv
Financial Calendar
Year-End Report: 2021-02-18
Q1-report: 2021-04-14
Annual General Meeting: 2021-04-26
Q2-report: 2021-08-19
Q3-report: 2021-11-17
Year-End Report: 2022-02-16